David J. Mauro

Insider Reports History

Location
Washington Cross, PA
Signature
/s/Jonathan Golightly, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David J. Mauro:

Company Role Class Num Shares Value Price $ Report Date Ownership
RECURSION PHARMACEUTICALS, INC. Chief Medical Officer Class A Common Stock 225,429 $1,392,024 $6.18 15 Nov 2024 Direct
RECURSION PHARMACEUTICALS, INC. Chief Medical Officer Stock Option (Right to Buy) 381,426 15 Nov 2024 Direct
Codiak BioSciences, Inc. Chief Medical Officer Stock Option (Right to Buy) 190,000 24 Jan 2023 Direct
Prelude Therapeutics Inc Chief Medical Officer Employee Stock Option (Right to Buy) 137,610 05 Oct 2021 Direct
Codiak BioSciences, Inc. Chief Medical Officer Restricted Stock Units 80,000 16 Sep 2022 Direct
Prelude Therapeutics Inc Chief Medical Officer Common Stock 0 $3.77 05 Oct 2021 Direct

Insider Reports Filed by David J. Mauro

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RXRX RECURSION PHARMACEUTICALS, INC. 15 Nov 2024 1 -$25,855 4 Chief Medical Officer 19 Nov 2024, 18:26
RXRX RECURSION PHARMACEUTICALS, INC. 15 Aug 2024 1 -$94,637 4 Chief Medical Officer 19 Aug 2024, 19:09
RXRX RECURSION PHARMACEUTICALS, INC. 15 May 2024 1 -$8,679 4 Chief Medical Officer 17 May 2024, 19:12
RXRX RECURSION PHARMACEUTICALS, INC. 09 Feb 2024 4 -$19,090 4 Chief Medical Officer 13 Feb 2024, 19:03
RXRX RECURSION PHARMACEUTICALS, INC. 01 Jun 2023 2 $0 4 Chief Medical Officer 07 Jun 2023, 19:36
RXRX RECURSION PHARMACEUTICALS, INC. 01 Jun 2023 0 $0 3 Chief Medical Officer 07 Jun 2023, 19:35
/report/000089924323002758-mauro-david-j-2023-01-24 Codiak BioSciences, Inc. 24 Jan 2023 1 $0 4 Chief Medical Officer 26 Jan 2023, 15:15
/report/000089924322031587-mauro-david-j-2022-09-16 Codiak BioSciences, Inc. 16 Sep 2022 1 $0 4 Chief Medical Officer 20 Sep 2022, 16:15
/report/000089924322016604-mauro-david-j-2022-05-02 Codiak BioSciences, Inc. 02 May 2022 2 $0 4 Chief Medical Officer 04 May 2022, 16:29
/report/000089924322016602-mauro-david-j-2022-05-02 Codiak BioSciences, Inc. 02 May 2022 0 $0 3 Chief Medical Officer 04 May 2022, 16:25
PRLD Prelude Therapeutics Inc 05 Oct 2021 5 -$436,000 4 Chief Medical Officer 06 Oct 2021, 18:02
PRLD Prelude Therapeutics Inc 07 Sep 2021 5 -$521,933 4 Chief Medical Officer 09 Sep 2021, 16:53
PRLD Prelude Therapeutics Inc 05 Aug 2021 6 -$438,044 4 Chief Medical Officer 09 Aug 2021, 16:26
PRLD Prelude Therapeutics Inc 20 Jul 2021 1 $0 4 Chief Medical Officer 22 Jul 2021, 18:13
PRLD Prelude Therapeutics Inc 06 Jul 2021 5 -$383,757 4 Chief Medical Officer 08 Jul 2021, 17:41
PRLD Prelude Therapeutics Inc 07 Jun 2021 5 -$458,272 4 Chief Medical Officer 09 Jun 2021, 18:24
PRLD Prelude Therapeutics Inc 05 May 2021 5 -$573,742 4 Chief Medical Officer 10 May 2021, 16:37